Improved closure of patent ductus arteriosus with high doses of ibuprofen

Pediatric Cardiology

Volumn 33, Issue 4, 2012, Pages 586-590

  Meißner, Udo ^a   Chakrabarty, Raktima ^a   Topf, Hans Georg ^a   Rascher, Wolfgang ^a   Schroth, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Ibuprofen; Neonates; Outcome; Patent ductus arteriosus; Surgery

Indexed keywords

IBUPROFEN;

CLINICAL ARTICLE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG TREATMENT FAILURE; HUMAN; INFANT; NEWBORN; PATENT DUCTUS ARTERIOSUS; RETROSPECTIVE STUDY; REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

BODY WEIGHT; CARDIAC SURGICAL PROCEDURES; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IBUPROFEN; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84863475453     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0182-2     Document Type: Review

References (27)

1. Aranda JV, Thomas R (2006) Systematic review: intravenous ibuprofen in preterm newborns. Semin Perinatol 30:114-120 (Pubitemid 43928131)
2. Attridge JT, Clark R, Gordon PV (2006) New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation. J Perinatol 26:667-670 (Pubitemid 44650183)
3. Bancalari E, Claure N, Gonzalez A (2005) Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 88:192-201 (Pubitemid 41433551)
4. Bose CL, Laughon MM (2007) Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 92:F498-F502 (Pubitemid 350063851)
5. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G, Odrezin GT, Cutter GR, Kirklin JK, Pacifico AD et al (1989) A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1.000 g or less at birth. N Engl J Med 320:1511-1516 (Pubitemid 19145802)
6. Cloherty JP, Eichenwald EC, Stark AR (2007) Manual of neonatal care, 6th edn. Lippincott Williams & Wilkins, Baltimore
7. Clyman RI (2006) Mechanisms regulating the ductus arteriosus. Biol Neonate 89:330-335 (Pubitemid 43886949)
8. Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, Rey E, Treluyer JM (2005) Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther 30:121-132 (Pubitemid 41583606)
9. Dykes FD, Lazzara A, Ahmann P, Blumenstein B, Schwartz J, Brann AW (1980) Intraventricular hemorrhage: a prospective evaluation of etiopathogenesis. Pediatrics 66:42-49 (Pubitemid 10033802)
10. Evans N, Kluckow M (1996) Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 75:F183-F186 (Pubitemid 126439147)
11. Hamrick SE, Hansmann G (2010) Patent ductus arteriosus of the preterm infant. Pediatrics 125:1020-1030
12. Herrera C, Holberton J, Davis P (2007) Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev CD003480. doi:10.1002/14651858.CD003480.pub3 (Pubitemid 351805883)
13. Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S (2008) An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 65:629-636 (Pubitemid 351535097)
14. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia OS (2002) Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 161:202-207 (Pubitemid 34253337)
15. Little DC, Pratt TC, Blalock SE, Krauss DR, Cooney DR, Custer MD (2003) Patent ductus arteriosus in micropreemies and fullterm infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg 38:492-496 (Pubitemid 36278718)
16. Malviya M, Ohlsson A, Shah S (2008) Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev CD003951. doi:10.1002/14651858. CD003951.pub2 (Pubitemid 351807685)
17. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM (1999) Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of verylow- birthweight infants. North Carolina Neonatologists Association. Pediatrics 104:1345-1350
18. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C (1997) Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 131:549-554 (Pubitemid 28006927)
19. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, Sekar K (2009) Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123:e138-e144
20. Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA, Stoll BJ, Poole K, Wright LL (2005) Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely lowbirthweight infants. J Pediatr 147:786-790 (Pubitemid 41774834)
21. Ohlsson A, Walia R, Shah S (2008) Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low-birthweight infants. Cochrane Database Syst Rev CD003481. doi:10.1002/ 14651858.CD003481.pub3 (Pubitemid 351824590)
22. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF (1999) Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135:733-738 (Pubitemid 30180423)
23. Ryder RW, Shelton JD, Guinan ME (1980) Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 112:113-123 (Pubitemid 10019007)
24. Smith GC (1998) The pharmacology of the ductus arteriosus. Pharmacol Rev 50:35-58
25. Sperandio M, Beedgen B, Feneberg R, Huppertz C, Brussau J, Poschl J, Linderkamp O (2005) Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Pediatrics 116:1361-1366 (Pubitemid 46056483)
26. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries JP (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674-681
27. Weiss H, Cooper B, Brook M, Schlueter M, Clyman R (1995) Factors determining reopening of the ductus arteriosus after successful clinical closure with indomethacin. J Pediatr 127: 466-471